GSK has been found guilty of bringing discredit on the pharma industry after a complainant flagged “a shocking error” in the prescribing information for the JAK inhibitor Omjjara. A person who ...

British pharmaceutical giant GSK has not met required ethical and regulatory standards in the marketing and prescription ...

GSK Pharma had reported a consolidated net profit of Rs 230 crore for Q3 FY25. This marks a significant surge of nearly 400 percent from the Rs 46 crore net profit reported in Q3 of previous ...

Associate Global Pharmaceutical Analyst at GlobalData. She added that GSK may be getting more bang per buck in terms of its R&D investment, with seven drugs in pre-registration phase compared with ...

British drugmakers GSK and AstraZeneca, as well as Danish company Novo Nordisk rose between 1.5% and 2%, reflecting the relief that pharmaceutical ... by Rishika Sadam in Hyderabad and Manas ...